Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest update is out from Beijing Tong Ren Tang Chinese Medicine Co ( (HK:3613) ).
Beijing Tong Ren Tang Chinese Medicine Co announced significant changes in its executive leadership, with the resignation of Mr. Chen Fei from multiple roles, including executive director and member of the competition executive committee, effective May 12, 2025. The company expressed gratitude for Mr. Chen’s contributions. Concurrently, Mr. Yue Zheng has been appointed as an executive director and vice chairman of the board, while Mr. Yan Han has taken on roles as an executive director, member of the competition executive committee, and authorized representative. These appointments are expected to influence the company’s strategic direction and reinforce its leadership structure.
More about Beijing Tong Ren Tang Chinese Medicine Co
Beijing Tong Ren Tang Chinese Medicine Co is a company incorporated in Hong Kong, operating within the traditional Chinese medicine industry. It focuses on the production and distribution of Chinese medicinal products and is part of the larger Beijing Tong Ren Tang Group, which has a significant presence in the Chinese medicine market.
YTD Price Performance: -2.16%
Average Trading Volume: 1,544,980
Technical Sentiment Signal: Sell
Current Market Cap: HK$7.19B
Learn more about 3613 stock on TipRanks’ Stock Analysis page.